8-K: Allstate to Sell Group Health Business to Nationwide for $1.25 Billion

Allstate Corporation has reached a definitive agreement to sell its Group Health business to Nationwide for $1.25 billion in cash.

Summary

• Allstate Corporation has agreed to sell its Group Health business to Nationwide for $1.25 billion in cash.
• The transaction includes the sale of Direct General Life Insurance Company, NSM Sales Corporation, and The Association Benefits Solution, LLC.
• The sale is subject to regulatory approvals and other customary closing conditions.
• For the first nine months of 2024, the Group Health business had revenues of $608 million and Adjusted Net Income of $69 million.
• The sale is expected to generate a financial book gain of about $450 million and increase deployable capital by $0.9 billion.
• The transaction is expected to close in 2025.
• When combined with the previously announced sale of Employer Voluntary Benefits to StanCorp Financial Group, Inc., (The Standard), total sale proceeds will be $3.25 billion.
• The Individual Health business, with Adjusted Net Income of $18 million for the first nine months of 2024, will either be retained or combined with another company.

Sentiment

Score: 7

Explanation: The announcement is generally positive, highlighting a strategic sale that will generate cash and a book gain for Allstate. However, there is a slight negative impact on adjusted net income return on equity.

Positives

• The sale will generate $1.25 billion in cash for Allstate.
• Allstate expects a financial book gain of approximately $450 million from the sale.
• Deployable capital is expected to increase by $0.9 billion.
• The transaction allows Allstate to focus on its core businesses.
• Nationwide will benefit from expanding its product portfolio and distribution capabilities.
• Total sale proceeds from the sale of Employer Voluntary Benefits to StanCorp Financial Group, Inc., (The Standard) will be $3.25 billion.

Negatives

• The sale is expected to reduce adjusted net income return on equity by 75 basis points after closing.
• The sale requires regulatory approvals and is subject to customary closing conditions, which could delay or prevent the transaction.
• Allstate acquired the Group Health business in 2021 as part of the $4.0 billion acquisition of National General.

Risks

• The transaction is subject to regulatory approvals, which may not be obtained.
• Customary closing conditions may not be met, potentially delaying or preventing the sale.
• The estimates, assumptions, or plans underlying the forward-looking statements prove inaccurate or if other risks or uncertainties arise, actual results could differ materially from those communicated in these forward-looking statements.

Future Outlook

The sale is expected to close in 2025. Allstate will either retain or combine the Individual Health business with another company.

Management Comments

• 'We reached another milestone in the strategy to maximize shareholder value by combining the Health & Benefits businesses with companies that have greater strategic alignment,' said Tom Wilson, Allstates Chair, President and CEO.
• 'Nationwide is extremely well capitalized and this transaction advances its growth strategy by expanding its product portfolio and distribution capabilities,' said Jess Merten, Allstates Chief Financial Officer.

Industry Context

The transaction reflects a trend of consolidation and strategic realignment within the insurance industry, as companies seek to optimize their portfolios and focus on core competencies. Allstate's decision to sell its Group Health business aligns with this trend, allowing the company to streamline its operations and allocate capital to other areas.

Comparison to Industry Standards

• The sale of Allstate's Group Health business to Nationwide for $1.25 billion is comparable to other transactions in the insurance industry, such as StanCorp Financial Group, Inc., (The Standard).
• These transactions often involve companies divesting non-core assets to focus on their primary lines of business.
• The valuation metrics, such as the price-to-revenue and price-to-earnings ratios, can be compared to similar deals to assess the fairness of the transaction.

Stakeholder Impact

• Shareholders will benefit from the increased cash and potential book gain.
• Employees of the Group Health business will transition to Nationwide.
• Customers of the Group Health business will gain access to Nationwide's complementary product offerings.

Next Steps

• Obtain regulatory approvals for the transaction.
• Satisfy customary closing conditions.
• Complete the sale of the Group Health business to Nationwide.
• Determine the future of the Individual Health business (retain or combine with another company).

Key Dates